2Trapani S, Micheli A, Grisolia F, et al. Henoch schonlein purpura in childhood: epidemiological and clinical analysis of 150 cases over a 5-year period and review of literature [J]. Semin Arthritis Rheum, 2005,35 (3) : 143-153.
5Narchi H. Risk of long term renal impairment and duration of follow up recommended for Henoch-Schonlein purpura with normal or minimal urinary findings: a systematic review [J]. Arch Dis Child, 2005,90(9) : 916-920.
6Chang W L, Yang Y H, Wang L C, et al. Renal manifestations in Henoch- Schonlein purpura: a 10-year clinical study [J]. Pediatr Nephrol, 2005,20 (9) : 1269-1272.
7Ozkaya O, Bek K, Alaca N, et al. Cerebral vasculitis in a child with Henoch-Schonlein purpura and familial Mediterranean fever [J]. Clin Rheuma- tol, 2007,26(10) : 1729-1732.
8Belman A L, Leicher C R, Moshe S L, et al. Neurologic manifestations of Schonlein-Henoch purpura: report of three cases and review of the literature [J]. Pediatrics, 1985,75 (4):657- 692.
6Bermadez Recio FJ, Gavilan Carrasco JC, Toro Sanchez R, et al. Purpura fulminans as complication of mycoplasma pneumoniae infection [J]. Med Clin(Barc), 1999,112(8):318-319.
7Mills JA,Michel BA,Bloch DA,et al.The American College of Rheumatology 1990 criteria for the classification of Henoch-Schoenlein purpura.Arthritis Rheum,1990,33(8):1114
8Belman AL,Leicher CR,Moshe SL,et al.Neurologic manifestations of Schoenlein-Henoch purpura:report of three cases and review of the literature.Pediatrics .1985,75(4):687
9Woolfenden AR,Trejo O,Perea M,et al.Neurologic manifestations of Schoenlein-Henoch purpura.Med Clin,2000,114(9):356
10Ha TS,Cha SH.Cerebral vasculitis in Henoch-Schoenlein purpura:a case report with sequential magnetic resonance imaging.Pediatr Nephrol,1996,10(5):634
2Yukihiko Kawasaki. The pathogenesis and treatment ofpediatric Henoch-Schonlein purpura nephritis [J]. Clin ExpNephrol, 2011,15(5):648-657.
3Mills J A, Michel B A,Bloch DA, et al. The Americancollege of rheumatology 1990 critera for the classification ofHenoch-Schonlein purpura [J]. A rthritis Rheum, 1990,33?8):1114-1121.
4Guissa V R, Aragao P A, Marques H H, et al. Chronicactive Epstein-Barr virus infection mimicking Henoch-Schonleinpurpura [J]. Acta Reumatol Port, 2010,35(5) ;513-517.
5Schuetz P, Batschwaroff M, Dusemund F, et al. Effectivenessof a procalcitonin algorithm to guide antibiotic therapy inrespiratory tract infections outside of study conditions : a post-study survey [J]. Eur J Clin Microbiol Infect Dis, 2010,29(3):269-277.
6Wakaki H, Ishikura K,Hataya H, et al. Henoch-Schonleinpurpura nephritis with nephrotic state in children : predictors ofpoor outcomes [J]. Pediatr Nephrol, 2011,26(6) ; 921-925.
7Chen 0 , Zhu XB, Ren P , et al. Henoch Schonlein Purpura inchildren: clinical analysis of 120 cases[J]. Afr Health Sci, 2013,13(1/:94-99.
8Kawasaki Y,Ono A, Ohara S,et al. Henoch-Schnlein purpura nephritis in childhood: pathogenesis, prognostic factors andtreatmentrJ~. Fukushima J Med Sci,2013,59(1) :15-26.
9Saulsbury FT, Henoch-Schnlein purpura [J]. Current opinion in rheumatology, 2010,22 ( 5 ) : 598-602.
10Demircin G, Oner A, Unver Y, et al. Erythroeyte superoxide dismutase activily and plasma malondiaidehyde levels in children with Henoch- Schonlein purpura [J]. Acta l?aediatr, 1998,87 (8) : 848-852.
